These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6189515)

  • 1. Binding of hormones and neuropeptides by calmodulin.
    Malencik DA; Anderson SR
    Biochemistry; 1983 Apr; 22(8):1995-2001. PubMed ID: 6189515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of simple peptides, hormones, and neurotransmitters by calmodulin.
    Malencik DA; Anderson SR
    Biochemistry; 1982 Jul; 21(14):3480-6. PubMed ID: 6180761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M; Carlquist M; Maletti M; Marie JC
    FEBS Lett; 1993 Feb; 318(1):35-40. PubMed ID: 8382169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretin, glucagon, gastric inhibitory polypeptide, parathyroid hormone, and related peptides in the regulation of the hypothalamus- pituitary-adrenal axis.
    Nussdorfer GG; Bahçelioglu M; Neri G; Malendowicz LK
    Peptides; 2000 Feb; 21(2):309-24. PubMed ID: 10764961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide binding by calmodulin and its proteolytic fragments and by troponin C.
    Malencik DA; Anderson SR
    Biochemistry; 1984 May; 23(11):2420-8. PubMed ID: 6148100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropin, vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal.
    Li ZG; Queen G; LaBella FS
    Endocrinology; 1990 Mar; 126(3):1327-33. PubMed ID: 1968378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activation.
    Giedroc DP; Keravis TM; Staros JV; Ling N; Wells JN; Puett D
    Biochemistry; 1985 Feb; 24(5):1203-11. PubMed ID: 3006746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin.
    Stallwood D; Brugger CH; Baggenstoss BA; Stemmer PM; Shiraga H; Landers DF; Paul S
    J Biol Chem; 1992 Sep; 267(27):19617-21. PubMed ID: 1527080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of structure to storage and receptor binding of glucagon.
    Blundell TL; Dockerill S; Sasaki K; Tickle IJ; Wood SP
    Metabolism; 1976 Nov; 25(11 Suppl 1):1331-6. PubMed ID: 185492
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration by covalent cross-linking of a specific interaction between beta-endorphin and calmodulin.
    Giedroc DP; Puett D; Ling N; Staros JV
    J Biol Chem; 1983 Jan; 258(1):16-9. PubMed ID: 6294097
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity.
    Gespach C; Emami S; Rosselin G
    Biochem Biophys Res Commun; 1984 Apr; 120(2):641-9. PubMed ID: 6329177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. des-(1-13) human beta-endorphin interacts with calmodulin.
    Puett D; Giedroc DP; Tollefson S; Ling N
    Peptides; 1983; 4(2):191-4. PubMed ID: 6312432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among several different non-homologous polypeptide hormones.
    Epand RM
    Mol Cell Biochem; 1983; 57(1):41-7. PubMed ID: 6316122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of beta-endorphin and other opioid peptides with calmodulin.
    Sellinger-Barnette M; Weiss B
    Mol Pharmacol; 1982 Jan; 21(1):86-91. PubMed ID: 6290868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
    Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
    Binder HJ; Lemp GF; Gardner JD
    Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lysosomes and proteases in hormone secretion and degradation.
    Chertow BS
    Endocr Rev; 1981; 2(2):137-73. PubMed ID: 6117463
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional interactions between smooth muscle myosin light chain kinase and calmodulin.
    Malencik DA; Anderson SR; Bohnert JL; Shalitin Y
    Biochemistry; 1982 Aug; 21(17):4031-9. PubMed ID: 6896995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of beta-endorphin residues 14-25 as a region involved in the inhibition of calmodulin-stimulated phosphodiesterase activity.
    Giedroc DP; Ling N; Puett D
    Biochemistry; 1983 Nov; 22(24):5584-91. PubMed ID: 6317022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.